Table 1. Recombinant adenoviruses used in this study.
Virus | Short | Replication | FK | IV/ml | Reference |
---|---|---|---|---|---|
MAdV-1-IX-2A-GFP | M1-IX-G | Competent | M1 | 2.7 x 106 b | This study |
MAdV-1-ΔE1A-GFP | M1-ΔE1A-G | Competent | M1 | 1.0 x 107 b | This study |
MAdV-2-ΔE1A-GFP | M2-ΔE1A-G | Competent | M2 | 4.4 x 107 b | This study |
MAdV-3-IX-2A-GFP | M3-IX-G | Competent | M3 | 1.0 x 107 b | This study |
MAdV-3-ΔE1A-GFP | M3-ΔE1A-G | Competent | M3 | 0.43 x 107 b | This study |
HAdV-C5-ΔE3B-CMV-GFP-FK-M1 | H5-ΔE3B-CG-FK-M1 | Competent | M1 | 6.8 x 108 c | This study |
HAdV-C5-ΔE3B-CMV-GFP-FK-M3 | H5-ΔE3B-CG-FK-M3 | Competent | M3 | 1.0 x 108 c | This study |
HAdV-C5-ΔE3B-CMV-GFP | H5-ΔE3B-CG | Competent | H5 | 8.0 x 1010 c | This study |
HAdV-C5-ΔE1-CMV-GFP | H5-ΔE1-CG | Defective | H5 | 1.1 x 1010 c | [65] |
HAdV-B3-ΔE1-CMV-GFP | H3-ΔE1-CG | Defective | H3 | 4.0 x 109 c | [66] |
HAdV-B35-ΔE1-CMV-GFP-E4orf6-HAdV-C5 | H35-ΔE1-CG | Defective | H35 | 1.0 x 109 c | This study |
a IV, infectious virus
b Titer was determined by GFP IFU assay, infecting CMT-93 cells.
c Titer was determined by plaque assay, infecting 911 cells.